Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain.Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a limited number of replica

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types. Stem cells are still a relatively new discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first culturing of embryonic stem cells from non-human primates occurred. Induced pluripotent stem cells were not produced until 2006. As a result of these discoveries, stem

This global strategic report evaluates strategies across the stem cell product spectrum, with emphasis on opportunities for stem cell research product development. It explores unique market opportunities by stem cell type, broken down by mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), neural stem cells (NSCs), and more.The possibilities arising from stem cells have resulted in great commercial interest, with po

Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, and potentially, other cell types. For years it has been clear that MSCs are a leading type of stem cell being investigated for therapeutic applications, because they have the potential to treat a wide range of acute and degenerative diseases.In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alt

This 204 page global strategic report is a must-read document for cord blood banking executives and investors. In addition to containing market size, segments, trends, and projections through 2020, it contains a 40-question, 52-page survey of 600+ recent and expectant parents worldwide. Additionally, BioInformant has been tracking the cord blood banking industry for a decade (2006 to present) using dashboards of key industry metrics, combined with a system of alerts that identify unexpected vari

Recent years have seen the first iPSC clinical trial in humans, creation of the world’s largest iPSC biobank, major funding awards, announcement of an iPSC cellular therapy clinic scheduled to open in Japan 2019, and much more. Furthermore, iPSC patent dominance is clustering in specific geographic regions, identifying “hot spots” for iPSC innovation. Trends in clinical trial and scientific publication rates also give clear indicators of what may happen in the industry in 2016 and beyond.